Stock Under $10 with 50-100% upside potential - 14 Days FREE!

7 Stocks Soaring on Unusual Volume

Stock quotes in this article: AMSG, OMER, ONXX, MPWR, SGEN, CMTL, LMNX 

Seattle Genetics (SGEN)

This is a biotechnology company focused on the development and commercialization of monoclonal antibody-based therapies for cancer. This stock is up 4% at $23.35 in recent trading.

Today's Volume: 2,705,000
Average Volume: 1,207,540
Volume % Change: 181%

Shares of SGEN are ripping higher today after Needham & Company reiterated its buy rating on the stock and raised its price target from $20 to $25.

From a technical perspective, SGEN is ripping to the upside here on monster volume. This move marks a continuation pattern for the stock after it broke out above $21.99 to $22.40 a few days ago with strong volume. As long as SGEN can maintain its trend above $21.99 to $22.40 with strong upside volume flows, this stock could possibly hit $25 to $27 soon.

Traders should consider any upside volume day that registers near or above 1,207,540 shares as bullish. Look for long-biased trades as long as it holds those breakout levels with volume.

On the flipside, I would avoid SGEN, or look for short-biased trades, if it moves back below $22 to $21 with heavy volume. If we get that action, look for SGEN to simply retest its 50-day at $19.84, or its 200-day at $18.69.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Dividend Stock Advisor
TRY IT FREE
New! $49.95/yr

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Real Money
TRY IT FREE

24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.

Product Features:
  • Jim Cramer + 20 Wall Street pros
  • Intraday commentary & news
  • Real-time trading forum
  • Actionable trade ideas
Real Money Pro
TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass + 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 15,294.50 -12.67 -0.08%
NASDAQ 3,459.42 -3.88 -0.11%
S&P 500 1,650.51 -4.84 -0.29%
US 10 Yr 2.018% -0.005

Brokerage Partners

Advertising Partners
Special Features

Free Newsletters from TheStreet

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy. Manage Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs